Lepu Biopharma Co., Ltd.

Direct answer

Lepu Biopharma Co., Ltd. is publicly traded on HKSE under the ticker 2157.HK.

Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse...

Can you invest in Lepu Biopharma Co., Ltd.?

Yes. Lepu Biopharma Co., Ltd. is publicly traded on HKSE under the ticker 2157.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Lepu Biopharma Co., Ltd.

Detailed equity research is provided by MarketSnap.